The conversation about menopause has finally moved past hot flushes, but most women are still under-served on the mental health side of the transition. This post is a consultant psychiatrist’s account of why menopause causes anxiety, how long it usually lasts, and what the current UK clinical evidence — including the updated NICE menopause guideline (NG23) — says actually helps.
Important framing before we start. “What helps” is genuinely individual. This post explains the evidence-based options that exist; it does not prescribe one for you. Decisions about treatment, especially medication, belong with your GP, gynaecologist or psychiatrist who knows your full clinical picture.
Does menopause cause anxiety?
Yes — menopause and perimenopause commonly cause new or worsening anxiety, driven by fluctuating oestrogen levels affecting brain chemistry, alongside disrupted sleep, hot flushes and other physical symptoms.
Oestrogen does much more than regulate the menstrual cycle. It modulates serotonin, GABA and noradrenaline — three neurotransmitter systems directly involved in mood and anxiety. When oestrogen levels start to fluctuate unpredictably in perimenopause (typically from your early-to-mid forties), the brain experiences something closer to a withdrawal pattern than a smooth decline, and the nervous system reacts.
The clinical picture varies, but the most common presentations are:
- New-onset anxiety in a woman who has never previously experienced it
- Worsening of pre-existing anxiety, often with new physical symptoms (heart racing, chest tightness, dread on waking)
- Panic attacks, sometimes for the first time in life
- Health anxiety, particularly about cardiac symptoms — palpitations are a common menopause symptom and can themselves trigger anxiety
- Anxiety layered on disrupted sleep, where waking at 3am becomes a regular event
The NICE menopause guideline (NG23, updated November 2024 and amended April 2026) explicitly lists “effects on mood, for example depressive symptoms” alongside vasomotor and genitourinary symptoms. The 2024 update also strengthened recommendations on cognitive behavioural therapy (CBT) as an evidence-based intervention for menopausal symptoms.
How long does menopause anxiety last?
Menopause-related anxiety typically lasts as long as the perimenopausal transition — most commonly 4 to 8 years, but it can range from a few months to more than a decade.
To understand the duration question, it helps to be clear on the stages:
- Perimenopause — the transition phase, usually starting in the mid-to-late forties, lasting an average of 4–5 years but anywhere from 2 to 10. Hormonal fluctuation is at its most unpredictable, and this is when anxiety symptoms are usually most pronounced.
- Menopause — defined as 12 consecutive months without a period. After this point, oestrogen levels are low but more stable.
- Postmenopause — the years after. For most women, mood-related symptoms ease in postmenopause as the nervous system adjusts to stable (if low) hormone levels. For some, particularly those with a history of anxiety or depression, symptoms persist longer and benefit from continued treatment.
Two practical points. First, anxiety that starts in perimenopause often improves substantially once oestrogen stabilises in postmenopause — but “improves” is not the same as “disappears,” and waiting it out is not the only option. Second, the duration is not entirely out of your control: sleep, exercise, alcohol intake, caffeine, and treatment choices all affect how long symptoms last and how disruptive they feel.
What helps with menopause anxiety?
UK clinical guidance recommends three evidence-based approaches: hormone replacement therapy (HRT) where the anxiety is hormonally driven, cognitive behavioural therapy (CBT), and lifestyle changes to sleep, exercise and alcohol intake. SSRIs are not first-line.
The current NICE-aligned framework, written for the patient rather than the clinician:
1. Hormone replacement therapy (HRT) — where appropriate
NICE NG23 recommends considering HRT to alleviate low mood that arises as a result of the menopause. The same logic extends to menopausal anxiety where it is hormonally driven, particularly when it co-occurs with other menopause symptoms (vasomotor, sleep disruption, joint pain).
HRT is not the right answer for every woman. The decision involves your personal and family medical history, your symptom pattern, your preferences, and a discussion of the small risk increases NICE has documented for some conditions. The 2024 NG23 update produced an HRT discussion aid specifically to support this conversation with your GP. It is a decision worth taking time over and worth discussing with a clinician who is comfortable prescribing HRT — not all GPs are.
What I would emphasise as a psychiatrist: if your anxiety is genuinely menopause-driven, treating it with HRT (where clinically appropriate) addresses the cause rather than the symptom, and is often more effective than treating the anxiety alone.
2. Cognitive behavioural therapy (CBT)
The 2024 NICE update strengthened CBT’s place in menopause care. Evidence reviewed by NICE shows CBT can reduce hot flushes and night sweats, improve sleep, and address anxiety and low mood — used alongside HRT or as an evidence-based alternative for women who can’t or choose not to take HRT.
Menopause-adapted CBT is now available through some NHS services, through IAPT/Talking Therapies in many areas, and privately. It is structured (typically 6–10 sessions), evidence-based, and specifically helpful for the cycle of physical symptom → anxious response → worsened physical symptom that menopausal anxiety can lock into.
3. Lifestyle foundations
Not optional, not a substitute for treatment, but genuinely effective and often underestimated:
- Sleep. Menopausal sleep disruption (night sweats, 3am waking, harder-to-fall-back-asleep) is one of the largest drivers of next-day anxiety. Sleep hygiene, a cool bedroom, and treatment of the underlying cause (often hormonal) all matter.
- Movement. Regular aerobic exercise has good evidence for reducing both menopausal symptoms and anxiety, independently. Weight-bearing exercise also protects bone density, which matters in postmenopause.
- Alcohol and caffeine. Both reliably worsen menopausal anxiety in women who are sensitive — alcohol disrupts the second half of the night’s sleep, caffeine amplifies the physiological symptoms (heart racing, chest tightness) that menopausal anxiety latches onto.
- The basics of nervous-system regulation. Slow breathing, time outdoors, and protected non-stimulating time before sleep are not glamorous, but they shift the baseline.
What about SSRIs and other antidepressants?
This is where clinical guidance and common practice still diverge. NICE NG23 is clear: SSRIs and SNRIs should not be routinely offered as first-line treatment for vasomotor symptoms alone, and there is no clear evidence they ease low mood in menopausal women who have not been diagnosed with depression.
That doesn’t mean antidepressants are never appropriate. Women who develop a diagnosable depressive or anxiety disorder during the menopausal transition are different from women experiencing menopause symptoms that include anxiety, and the treatment pathway is different. A consultant psychiatrist’s job is to help work out which picture you are presenting with — because the right intervention depends on that distinction.
If a GP has offered you an antidepressant for menopausal mood symptoms and you’re unsure, ask whether HRT and CBT have been considered first, what the diagnostic reasoning is, and what the plan is for review. Those are reasonable questions and you should expect clear answers.
Does HRT help with menopause anxiety?
For many women, HRT improves menopause-related anxiety alongside other menopausal symptoms — particularly when anxiety is hormonally driven and accompanied by sleep disruption, hot flushes or low mood.
The Reisel/Newson 2024 study cited at the start of this post found that, in their cohort, “attacks of anxiety and panic” improved by 61% on average after three months of HRT (with or without testosterone). That’s a large study cohort, though not a randomised trial, and individual response varies.
What this means in practice: if your anxiety is part of a wider menopausal picture and HRT is clinically appropriate for you, it is a reasonable first option to discuss with your prescriber. Improvement is usually noticeable within 6–12 weeks. If anxiety persists after 3 months on a settled HRT regimen, that is the point to consider adding CBT or, occasionally, a psychiatric review.
How to manage menopause anxiety: a practical sequence
If you are reading this because the anxiety is making daily life hard right now, this is the sequence I would suggest:
- Track what you’re experiencing. Two weeks of notes — when the anxiety hits, what was happening, sleep quality, alcohol the night before, where you were in your cycle if you’re still cycling. This makes the GP conversation faster and more useful.
- See your GP and ask specifically about menopause. Some GPs are confident menopause prescribers; others are not. Ask whether your symptoms could be hormonally driven, and what the options are. If you don’t get a satisfying conversation, it is reasonable to ask for a referral to a menopause specialist or to see a private menopause-focused clinician.
- Address the lifestyle foundations in parallel. Sleep, movement, alcohol, caffeine. These don’t replace clinical treatment, but they reduce the volume.
- Consider CBT, regardless of whether you start HRT. Menopause-adapted CBT is one of the best-evidenced interventions and works alongside any other treatment.
- If symptoms persist or are severe — chest tightness on waking, dread that doesn’t lift, panic attacks, intrusive low mood — seek psychiatric input. Distinguishing between menopausal anxiety, a developing anxiety disorder, and a depressive episode matters, because the treatments differ.
Make an Appointment with Flint Healthcare →
A note on safety
Please don’t manage severe or worsening anxiety alone. If you are having thoughts of harming yourself, or you feel you can’t cope, contact your GP, NHS 111, or Samaritans on 116 123 (free, 24/7). If you are in immediate danger, call 999. Menopause-related mental health symptoms are common and treatable; they are not something you have to wait out alone.
Menopause and mental health support in Brighton, Hove and online with Flint Healthcare
Flint Healthcare offers consultant-psychiatrist-led menopause and mental health support in Brighton (Woodingdean) and online UK-wide, including assessment and treatment of menopausal anxiety, low mood, and co-occurring mental health conditions.
We’re a CQC-registered service. Our consultant psychiatrists work alongside menopause specialists where indicated, and provide assessment and treatment for the psychiatric side of the menopausal transition — including the distinction between menopause-related anxiety and a primary anxiety or depressive disorder, which carry different treatment implications. Where HRT is the right answer, we work with your GP or a menopause specialist; where CBT or psychiatric treatment is indicated, we provide it directly. Available in person in Brighton, Hove, Rottingdean, Saltdean, Woodingdean, Lewes and Kemptown, and online via online mental health assessment anywhere in the UK.
You can read more about our team, or make an appointment. For Brighton, call 01273 468848.
Frequently asked questions
Is anxiety a common symptom of menopause?
Yes. A 2024 UK study published in BJPsych Open found that 90% of perimenopausal and menopausal women surveyed reported feeling “tense or nervous.” Psychological symptoms are now recognised as among the most common features of the menopausal transition, alongside vasomotor symptoms.
How do I know if my anxiety is menopause or something else?
The strongest indicators that anxiety is menopause-related are: timing (onset or worsening in your forties or early fifties), co-occurrence with other menopause symptoms (sleep disruption, hot flushes, joint pain, brain fog), and pattern (often worse in the second half of the menstrual cycle if you’re still cycling). A clinician can help work out whether you’re dealing with menopausal anxiety, a primary anxiety disorder, or both — the treatments differ.
Does HRT help with menopause anxiety?
For many women whose anxiety is hormonally driven, yes. NICE NG23 supports considering HRT for menopause-related low mood, and the same logic applies to anxiety in this context. Improvement is usually noticeable within 6–12 weeks of starting a settled regimen. Whether HRT is right for you depends on your personal medical history.
How to calm or manage menopause anxiety in the moment?
Slow nasal breathing (longer out-breath than in-breath) measurably reduces sympathetic nervous system activation. Cold-water hand or face exposure can interrupt acute panic. Naming what’s happening (“this is a panic response, it will peak in 10 minutes”) reduces the fear-of-fear cycle that prolongs anxiety. These are short-term tools, not treatment.
Should I take antidepressants for menopausal anxiety?
NICE does not recommend SSRIs or SNRIs as first-line treatment for menopausal symptoms in women without diagnosed depression. They may be appropriate for women whose menopausal transition includes a diagnosable anxiety or depressive disorder — that’s a clinical judgement that benefits from psychiatric or GP input. Always discuss with your prescriber.
In summary
Menopausal anxiety is real, common, and treatable. The current UK evidence supports HRT (where clinically appropriate), CBT (alone or alongside HRT), and lifestyle foundations as the first-line approaches — with antidepressants reserved for women who develop a diagnosable depressive or anxiety disorder, not for menopause symptoms alone. The most important thing you can do is have the conversation with a clinician who is comfortable with the menopause-mental-health overlap, and not assume you have to live with the anxiety until postmenopause arrives.
If you’d like to talk through what’s happening for you and what might help, make an appointment — the first conversation costs you nothing.
Last reviewed: 12 May 2026 · Next refresh: May 2027
